Remove topic all-cash-deal
article thumbnail

Cannabis Platform Vangst Acquires CannabizTeam's Temp Staffing Division Amid Hiring Surge

Benzinga

What Happened The company said on Friday the acquisition was 50% cash and 50% stock and is the first acquisition in the cannabis human resources (HR) space. Why It Matters The acquisition of CannabizTemp brings Vangst's total customer count to over 1,700, and Vangst now services 90% of all US multi-state cannabis operators.

98
article thumbnail

The Tragic Investment Banker Death: Should Senior Bankers Go to Jail for Killing Their Junior Staff?

Brian DeChesare

All these factors still play a role, but after seeing many of these stories, I’ve changed my mind about the hours. This gets especially bad whenever deal activity declines and MDs go “on the hunt” for new fees. Of course, not all bankers do this; many of the sane ones know you can’t just push employees to work 16 hours per day forever.

Banking 110
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Strategic Insights: Valuing Assets in Complicated Deals

RNC

Company valuation is a crucial component that can make or break a deal in the dynamic world of mergers, acquisitions, and other complex financial transactions. Accurate asset valuation is essential for determining a company’s value, as well as for ensuring that all parties involved benefit from a just and equitable resolution.

article thumbnail

The Twitter Buyout: Is Elon Musk a Madman or a Genius?

Brian DeChesare

This specific deal generates endless discussion topics: “Free speech” vs. “content moderation,” AKA censorship. These are all interesting topics, but since I am a depressing person, I will ignore them and focus on the numbers. I don’t think this deal is completely crazy, but I would say it is moderately crazy.

EBITDA 105
article thumbnail

Cooley’s 2023 Life Sciences M&A Year in Review: Potent Mix of Creativity and Resilience Spurs Activity Heading Into 2024

Cooley M&A

In a subdued year for global M&A, deal-making in the life sciences industry came in waves, with a busy fourth quarter generating cautious optimism heading into 2024. The last quarter of the year ended with a surge of deal activity. Why did life sciences outperform the market? billion and Cerevel Therapeutics for $8.7

article thumbnail

The Growth Equity Case Study: Real-Life Example and Tutorial

Brian DeChesare

These topics are interesting but difficult to demonstrate in a video tutorial or article, so we’ll focus on the financial modeling case here. The Balance Sheet and Cash Flow Statement forecasts use a similar approach: make most items simple percentages of Revenue, COGS, or OpEx. multiple of invested capital in this deal?

Equity 104
article thumbnail

The role of financial projections in startup valuation

Equidam

The valuation of early stage companies is a one of the more complex and contentious topic in the startup world. One topic which allows us to peer deeper into the logic behind early stage valuation is the role of financial projections. It’s all optimistic guesswork! These are all projections of a sort.